Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1998 1
1999 1
2000 1
2003 2
2004 3
2005 2
2006 5
2007 2
2009 3
2010 3
2011 6
2012 4
2013 5
2014 9
2015 9
2016 8
2017 2
2018 8
2019 9
2020 6
2021 18
2022 16
2023 17
2024 13
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Mechanisms of resistance to mogamulizumab.
Querfeld C. Querfeld C. Blood. 2022 Jun 30;139(26):3674-3676. doi: 10.1182/blood.2022016594. Blood. 2022. PMID: 35771561 Free article. No abstract available.
Pembrolizumab-associated sarcoidosis.
Cotliar J, Querfeld C, Boswell WJ, Raja N, Raz D, Chen R. Cotliar J, et al. Among authors: querfeld c. JAAD Case Rep. 2016 Jul 27;2(4):290-3. doi: 10.1016/j.jdcr.2016.06.004. eCollection 2016 Jul. JAAD Case Rep. 2016. PMID: 27504482 Free PMC article. No abstract available.
CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L, Zain J, Rosen ST, Querfeld C. Nikolaenko L, et al. Among authors: querfeld c. Cancer Treat Res. 2019;176:249-268. doi: 10.1007/978-3-319-99716-2_12. Cancer Treat Res. 2019. PMID: 30596222
Targeting microRNA in hematologic malignancies.
Han Z, Rosen ST, Querfeld C. Han Z, et al. Among authors: querfeld c. Curr Opin Oncol. 2020 Sep;32(5):535-544. doi: 10.1097/CCO.0000000000000657. Curr Opin Oncol. 2020. PMID: 32657797 Free PMC article. Review.
Approach to Mycosis Fungoides in children: Consensus-based recommendations.
Zvulunov A, Neale H, Stern J, Santaguida P, Stein AB, Koh M, Eichenfield LF, Guitart J, Goebeler M, Scarisbrick J, Willemze R, Coughlin CC, George R, Brazzelli V, Marschalkó M, Belousova I, Querfeld C, Bagot M, Szepietowski JC, Papadavid E, Quaglino P, Hoeger P, Ortiz-Romero PL, Nikolaou V, Dummer R, Aung PP, Lawley L, Morel KD, Ngan B, Wain M, Gameiro A, Lacy-Niebla RM, Pope E. Zvulunov A, et al. Among authors: querfeld c. J Am Acad Dermatol. 2024 Dec;91(6):1078-1085. doi: 10.1016/j.jaad.2024.07.1501. Epub 2024 Aug 23. J Am Acad Dermatol. 2024. PMID: 39181404
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.
Goyal A, O'Leary D, Dabaja B, Weng WK, Zain J, Cutler C, Guitart J, Kim YH, Geskin LJ, Hoppe RT, Wilson LD, Beaven AW, Horwitz S, Allen PB, Barta SK, Bohjanen K, Brammer JE, Carter JB, Comfere N, DeSimone JA, Dusenbery K, Duvic M, Huen A, Jagadeesh D, Kelsey CR, Khodadoust MS, Lechowicz MJ, Mehta-Shah N, Moskowitz AJ, Olsen EA, Poh C, Pro B, Querfeld C, Sauter C, Sokol L, Sokumbi O, Wilcox RA, Zic JA, Hamadani M, Foss F. Goyal A, et al. Among authors: querfeld c. Transplant Cell Ther. 2024 Nov;30(11):1047-1060. doi: 10.1016/j.jtct.2024.08.020. Epub 2024 Sep 1. Transplant Cell Ther. 2024. PMID: 39222792 Free article.
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.
Scarisbrick JJ, Quaglino P, Whittaker S, Bagot M, Guenova E, Papadavid E, Prince HM, Sanches JA, Miyashiro DR, Servitje O, Querfeld C, Akilov O, Arumainathan A, Bennett L, Battistella M, Benstead K, Berti E, Beylot-Barry M, Busschots AM, Cowan R, Dummer R, Dunnill G, Estrach T, Evison F, Bashir A, Geskin L, Gru A, Guitart J, Herrera MC, Hodak E, Horwitz S, Jonak C, Klemke CD, Knobler R, Mckay P, Marschalkó M, Massone C, Matin R, Mitteldorf C, Novoa R, Ortiz-Romero P, Pimpinelli N, Pujol RM, Ranki A, Vakeva L, Rieger KE, Stadler R, Trautinger F, Latzka J, Vermeer M, Wachsmuth R, Weatherhead S, Wehkamp U, Wobser M, Kim YH. Scarisbrick JJ, et al. Among authors: querfeld c. Blood. 2025 Oct 2;146(14):1687-1692. doi: 10.1182/blood.2025029628. Blood. 2025. PMID: 40663780 Clinical Trial.
146 results